My San Antonio– Purdue Pharma announced Tuesday a corporate turnaround specialist as its new board chairman and also changed its top lawyer, marking the latest in a series of organizational shifts for the embattled maker of the OxyContin opioid.
Business Law
Studying for the Bar? Put Down the Phone — Or Not
ABA Journal– The days of attending bar review classes in person are waning, say law school deans, and recent graduates preparing for the bar now do a great deal of studying on smartphones with offerings like streamed lectures, flashcard apps and even YouTube songs devoted to thinking through statutes and case law.
Purdue Pharma Faces Private-Sector Litigation
With Less Than 80 Days to Regulatory Deadline, Neo4j Urges Organizations to Turn GDPR Compliance Into Strategic Advantage
PR Newswire– In lead-up to GDPR’s looming May 25, 2018 deadline, Neo4j, the market leader in connected data, is urging any company that is investing in GDPR compliance to use those investments for a long-term, strategic advantage. As part of that effort, Neo4j is offering an interactive, personalized demonstration and solution assessment, which shows organizations how to use connected data to meet GDPR compliance, and also how to turn those compliance investments into a strategic advantage.
U.S. Seeks Repayment from Purdue Pharma
Senate Report Probes Purdue Pharma Donations to Nonprofits
Professor Stephen Park Named Satell CSR Fellow
Solutions to Climate Change, Poverty, Other Social Challenges Require Collective Effort, New Approaches
Business Law Professor Stephen Park has been named to the newly created position of Satell Fellow in Corporate Social Responsibility.
“The School of Business is deeply invested in the development of corporate social responsibility guidelines and shares the belief that this work is of utmost importance,” said Dean John A. Elliott. Continue Reading
Purdue Faces Uphill Battle to Overcome Opioid Controversy
New York’s Suit Against Purdue Pharma Could Have Major Impact
Stamford Advocate– New York City this week added a new dimension to the legal crisis facing Purdue Pharma.
The nation’s largest city is suing several pharmaceutical firms including Stamford’s Purdue, one of the most prominent of the many lawsuits that blame the company for fueling the opioid crisis.
Purdue Pharma, Prosecutors Continue Dialogue
Stamford Advocate – As a growing number of states pursue legal action against Purdue Pharma for allegedly stoking the nation’s opioid crisis, both sides are seeking to avoid protracted and costly cases.